Status and phase
Conditions
Treatments
About
Assessment of the therapeutic effect of deep brain stimulation of the subthalamic nucleus compared with drug treatment alone in patients with advanced Parkinson's disease.
Full description
Patients are randomized either to medical treatment or subthalamic stimulation. The observation period was 6 months. The primary outcome criterium: PDQ-39 and UPDRS III.
Sex
Ages
Volunteers
Inclusion criteria
advanced Parkinson's disease with UPDRS III score >29/104 or Dyskinesia score > 2 or tremor >2
Exclusion criteria
age>75 years depression psychosis surgical contraindications
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal